| 000 | 01628 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513051030.0 | ||
| 264 | 0 | _c19950425 | |
| 008 | 199504s 0 0 eng d | ||
| 022 | _a0029-7844 | ||
| 024 | 7 |
_a10.1016/0029-7844(94)00457-O _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWysowski, D K | |
| 245 | 0 | 0 |
_aSerious adverse events in Norplant users reported to the Food and Drug Administration's MedWatch Spontaneous Reporting System. _h[electronic resource] |
| 260 |
_bObstetrics and gynecology _cApr 1995 |
||
| 300 |
_a538-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAdverse Drug Reaction Reporting Systems _xstatistics & numerical data |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCerebrovascular Disorders _xchemically induced |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDebridement |
| 650 | 0 | 4 | _aDrainage |
| 650 | 0 | 4 | _aDrug Implants |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHospitalization _xstatistics & numerical data |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLevonorgestrel _xadverse effects |
| 650 | 0 | 4 | _aPlasmapheresis |
| 650 | 0 | 4 |
_aPseudotumor Cerebri _xchemically induced |
| 650 | 0 | 4 |
_aPurpura, Thrombotic Thrombocytopenic _xchemically induced |
| 650 | 0 | 4 |
_aSurgical Wound Infection _xdiagnosis |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 700 | 1 | _aGreen, L | |
| 773 | 0 |
_tObstetrics and gynecology _gvol. 85 _gno. 4 _gp. 538-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0029-7844(94)00457-O _zAvailable from publisher's website |
| 999 |
_c7898163 _d7898163 |
||